TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
CA68234M2058
Issuer Name
ONDINE BIOMEDICAL INC
UK or Non-UK Issuer
Non-UK
2. Reason for Notification
Other
Comments
This was caused by an IPO.
3. Details of person subject to the notification obligation
Name
M&G Plc
City of registered office (if applicable)
London
Country of registered office (if applicable)
United Kingdom
4. Details of the shareholder
Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above
City of registered office (if applicable)
Country of registered office (if applicable)
5. Date on which the threshold was crossed or reached
18-Nov-2024
6. Date on which Issuer notified
25-Nov-2024
7. Total positions of person(s) subject to the notification obligation
| % of voting rights attached to shares (total of 8.A) | % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) | Total of both in % (8.A + 8.B) | Total number of voting rights held in issuer | |
| Resulting situation on the date on which threshold was crossed or reached | 10.299591 | 0.000000 | 10.299591 | 40588235 |
| Position of previous notification (if applicable) | N/A | N/A | N/A | |
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
| Class/Type of shares ISIN code(if possible) | Number of direct voting rights (DTR5.1) | Number of indirect voting rights (DTR5.2.1) | % of direct voting rights (DTR5.1) | % of indirect voting rights (DTR5.2.1) |
| CA68234M2058 | | 40588235 | | 10.299591 |
| Sub Total 8.A | 40588235 | 10.299591% | ||
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
| Type of financial instrument | Expiration date | Exercise/conversion period | Number of voting rights that may be acquired if the instrument is exercised/converted | % of voting rights |
|
| | | | |
| Sub Total 8.B1 | | | | |
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
| Type of financial instrument | Expiration date | Exercise/conversion period | Physical or cash settlement | Number of voting rights | % of voting rights |
|
| | | | | |
| Sub Total 8.B2 | | | | ||
9. Information in relation to the person subject to the notification obligation
2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)
| Ultimate controlling person | Name of controlled undertaking | % of voting rights if it equals or is higher than the notifiable threshold | % of voting rights through financial instruments if it equals or is higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable threshold |
| M&G Plc | M&G Plc (Parent company) | 10.299591% | | 10.299591% |
| M&G Plc | M&G Group Regulated Entity Holding Company Limited (wholly owned subsidiary of M&G Plc) | 10.299591% | | 10.299591% |
| M&G Plc | M&G Group Limited (wholly owned subsidiary of M&G Group Regulated Entity Holding Company Limited) | 10.299591% | | 10.299591% |
| M&G Plc | M&G FA Limited (wholly owned subsidiary of M&G Group Limited) | 10.299591% | | 10.299591% |
| M&G Plc | M&G Investment Management Limited (wholly owned subsidiary of M&G FA Limited) | 10.299591% | | 10.299591% |
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
12. Date of Completion
25-Nov-2024
13. Place Of Completion
London, United Kingdom
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
